Drug Safety Settlement
Daiichi Sankyo says it was misled over Ranbaxy U.S. probes
Japanese drugmaker Daiichi Sankyo Co, which bought control of Ranbaxy Laboratories in 2008, said it believes unnamed former shareholders of the company hid information regarding U.S. regulatory probes into Ranbaxy. Full Article
- Soldier hacked to death in London in suspected Islamist attack
- FBI says man shot dead while being questioned about Boston bombings
- Short story writer Lydia Davis wins Man Booker International fiction prize
- Gold slips after Bernanke hints at slowing bond buys
- Gold slides as Fed chief hints at reduced bond buying
REUTERS SHOWCASE
Tax Avoidance
EU leaders talk tough on tackling Amazon, Google over taxes. Full Article | Related Story
Buy, Sell or Hold?
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
MARKET EYE-Indian shares flat amid choppy trade; ITC falls, Maruti gains
* The BSE index gains 0.05 percent and the NSE index is down 0.02 percent * ITC falls 0.5 percent on profit booking after it touched its all-time high of 303 rupees earlier in the day. * However, four-wheeler stocks such as Maruti Suzuki India gain. Maruti up 2.5 percent on reports of price hike in January. * Bahujan Samaj Party (BSP), which had abstained in the lower house, said it would vote in support of foreign direct investment in the upper house of parliament on Friday. * Traders say while markets remain susceptible to profit booking after India's benchmark index rose 5.6 percent till Thursday, since Nov. 22, when the winter session of parliament began, vote on FDI remains the key for near term direction. (abhishek.vishnoi@thomsonreuters.com /; abhishek.vishnoi.reuters.com@reuters.net)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints






Follow Reuters